Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.22.2.2
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 217 $ 3,763
Other receivables - related party   90
Deferred financing costs 338  
Prepaid expenses and other current assets 20 107
Total Assets 575 3,960
Current Liabilities:    
Accounts payable and accrued expenses 573 451
Accounts payable and accrued expenses - related party 41 58
Total current liabilities 614 509
Total Liabilities 614 509
Commitments and Contingencies
Stockholders' Equity (Deficit)    
Preferred Stock ($0.0001 par value), 2,000,000 shares authorized Class A Preferred Stock, 250,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021
Common Stock ($0.0001 par value), 20,000,000 shares authorized Common shares, 1,481,439 and 1,405,934 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively   2
Additional paid-in capital 81,087 80,448
Accumulated deficit (81,126) (76,999)
Total Stockholders' Equity (Deficit) (39) 3,451
Total Liabilities and Stockholders' Equity (Deficit) $ 575 $ 3,960